{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:12:51Z","timestamp":1790647971543,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Natural Science Foundation of Shanghai City, China"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.molimm.2016.08.006","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T20:17:30Z","timestamp":1470946650000},"page":"184-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Role of interleukin-4, the chemokine CCL3 and its receptor CCR5 in neuropathic pain"],"prefix":"10.1016","volume":"77","author":[{"given":"Shiyu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lengchen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2016.08.006_bib0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brainresrev.2008.12.002","article-title":"Chemokines and pain mechanisms","volume":"60","author":"Abbadie","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.molimm.2016.08.006_bib0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.it.2005.08.001","article-title":"Chemokines, chemokine receptors and pain","volume":"26","author":"Abbadie","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molimm.2016.08.006_bib0015","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1038\/cddis.2013.198","article-title":"CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury","volume":"4","author":"Akimoto","year":"2013","journal-title":"Cell. Death. Dis."},{"key":"10.1016\/j.molimm.2016.08.006_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpneuro0113","article-title":"Mechanisms of disease: neuropathic pain \u2013 a clinical perspective","volume":"2","author":"Baron","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.molimm.2016.08.006_bib0025","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/nn.3155","article-title":"P2\u00d74R+ microglia drive neuropathic pain","volume":"15","author":"Beggs","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molimm.2016.08.006_bib0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fncel.2014.00210","article-title":"Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic pain","volume":"8","author":"Biber","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.molimm.2016.08.006_bib0035","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/j.1471-4159.2004.02846.x","article-title":"STAT6 transcription factor binding sites with mismatches within the canonical 5\u2032-TTC...GAA-3\u2032 motif involved in regulation of delta- and mu-opioid receptors","volume":"91","author":"Borner","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molimm.2016.08.006_bib0040","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.molimm.2016.08.006_bib0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.expneurol.2011.08.018","article-title":"The mechanisms of microgliosis and pain following peripheral nerve injury","volume":"234","author":"Calvo","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molimm.2016.08.006_bib0050","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2016.08.006_bib0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bjp.0702266","article-title":"Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4","volume":"126","author":"Cunha","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.molimm.2016.08.006_bib0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1471-4159.2008.05429.x","article-title":"Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats","volume":"106","author":"Dansereau","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molimm.2016.08.006_bib0065","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1074\/jbc.273.21.12901","article-title":"Induction of cyclooxygenase-2 by the activated MEKK1\u2192SEK1\/MKK4\u2192p38 mitogen-activated protein kinase pathway","volume":"273","author":"Guan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2016.08.006_bib0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1744-8069-2-6","article-title":"HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain","volume":"2","author":"Hao","year":"2006","journal-title":"Mol. Pain"},{"issue":"5","key":"10.1016\/j.molimm.2016.08.006_bib0075","doi-asserted-by":"crossref","first-page":"e64528","DOI":"10.1371\/journal.pone.0064528","article-title":"The prevalence and phenotype of activated microglia\/macrophages within the spinal cord of the hyperostotic mouse (twy\/twy) changes in response to chronic progressive spinal cord compression: implications for human cervical compressive myelopathy","volume":"8","author":"Hirai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2016.08.006_bib0080","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1096\/fj.04-1642fje","article-title":"Inhibition of p38 MAP kinase- and RICK\/NF-kappaB-signaling suppresses inflammatory bowel disease","volume":"18","author":"Hollenbach","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.molimm.2016.08.006_bib0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1744-8069-3-33","article-title":"p38 MAPK, microglial signaling, and neuropathic pain","volume":"3","author":"Ji","year":"2007","journal-title":"Mol. Pain"},{"key":"10.1016\/j.molimm.2016.08.006_bib0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-4886(03)00268-1","article-title":"The p38 MAP kinase signaling pathway in Alzheimer's disease","volume":"183","author":"Johnson","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molimm.2016.08.006_bib0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneuroim.2011.02.003","article-title":"Interleukin-13 reduces hyperalgesia and the level of interleukin-1beta in BALB\/c mice infected with Leishmania major with an up-regulation of interleukin-6","volume":"234","author":"Karam","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2016.08.006_bib0100","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1523\/JNEUROSCI.3338-07.2008","article-title":"Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord","volume":"28","author":"Kawasaki","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molimm.2016.08.006_bib0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2010.07.085","article-title":"CC-chemokine MIP-1alpha in the spinal cord contributes to nerve injury-induced neuropathic pain","volume":"484","author":"Kiguchi","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molimm.2016.08.006_bib0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pain.2010.02.025","article-title":"Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation","volume":"149","author":"Kiguchi","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.molimm.2016.08.006_bib0115","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cyto.2013.09.019","article-title":"Epigenetic upregulation of CCL2 and CCL3 via histone modifications in infiltrating macrophages after peripheral nerve injury","volume":"64","author":"Kiguchi","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.molimm.2016.08.006_bib0120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/j.pain.0000000000000097","article-title":"Peripheral interleukin-4 ameliorates inflammatory macrophage-dependent neuropathic pain","volume":"156","author":"Kiguchi","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.molimm.2016.08.006_bib0125","doi-asserted-by":"crossref","first-page":"43901","DOI":"10.1074\/jbc.M107543200","article-title":"Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site","volume":"276","author":"Kraus","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2016.08.006_bib0130","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbi.2006.10.012","article-title":"Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats","volume":"21","author":"Ledeboer","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.molimm.2016.08.006_bib0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2012.10.030","article-title":"Decreased pain responses of C\u2013C chemokine receptor 5 knockout mice to chemical or inflammatory stimuli","volume":"67","author":"Lee","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molimm.2016.08.006_bib0140","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.pain.2012.03.008","article-title":"Absence of C\u2013C motif chemokine ligand 5 in mice leads to decreased local macrophage recruitment and behavioral hypersensitivity in a murine neuropathic pain model","volume":"153","author":"Liou","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.molimm.2016.08.006_bib0145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.molimm.2016.08.006_bib0150","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1365-2222.1996.tb00605.x","article-title":"TH2 cells in allergic inflammation: a target of immunotherapy","volume":"26","author":"Lord","year":"1996","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.molimm.2016.08.006_bib0155","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.pain.2014.09.027","article-title":"TRAF6 upregulation in spinal astrocytes maintains neuropathic pain by integrating TNF-alpha and IL-1beta signaling","volume":"155","author":"Lu","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.molimm.2016.08.006_bib0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuron.2009.09.033","article-title":"Current challenges in glia-pain biology","volume":"64","author":"McMahon","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.molimm.2016.08.006_bib0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1744-8069-1-9","article-title":"Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10","volume":"1","author":"Milligan","year":"2005","journal-title":"Mol. Pain"},{"key":"10.1016\/j.molimm.2016.08.006_bib0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000097238","article-title":"Intracerebroventricular injection of tumor necrosis factor-alpha induces thermal hyperalgesia in rats","volume":"3","author":"Oka","year":"1996","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.molimm.2016.08.006_bib0175","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0026-895X(25)10491-4","article-title":"Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence","volume":"48","author":"Perregaux","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.molimm.2016.08.006_bib0180","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1476-5381.1995.tb14987.x","article-title":"Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10","volume":"115","author":"Poole","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.molimm.2016.08.006_bib0185","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.immuni.2009.09.010","article-title":"Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology","volume":"31","author":"Ransohoff","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2016.08.006_bib0190","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1089\/scd.2012.0398","article-title":"Systemic administration of human adipose-derived stem cells reverts nociceptive hypersensitivity in an experimental model of neuropathy","volume":"22","author":"Sacerdote","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.molimm.2016.08.006_bib0195","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/j.1532-2149.2012.00146.x","article-title":"CC-chemokine ligand 4\/macrophage inflammatory protein-1beta participates in the induction of neuropathic pain after peripheral nerve injury","volume":"16","author":"Saika","year":"2012","journal-title":"Eur. J. Pain"},{"issue":"Suppl","key":"10.1016\/j.molimm.2016.08.006_bib0200","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/nn942","article-title":"Can we conquer pain?","volume":"5","author":"Scholz","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molimm.2016.08.006_bib0205","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molimm.2016.08.006_bib0210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pain.2007.11.019","article-title":"Low-dose methotrexate reduces peripheral nerve injury-evoked spinal microglial activation and neuropathic pain behavior in rats","volume":"138","author":"Scholz","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.molimm.2016.08.006_bib0215","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nn.4053","article-title":"Different immune cells mediate mechanical pain hypersensitivity in male and female mice","volume":"18","author":"Sorge","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molimm.2016.08.006_bib0220","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin: results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"J. Pain"},{"key":"10.1016\/j.molimm.2016.08.006_bib0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tins.2004.12.002","article-title":"Neuropathic pain and spinal microglia: a big problem from molecules in small glia","volume":"28","author":"Tsuda","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.molimm.2016.08.006_bib0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1994.tb39789.x","article-title":"Release and inactivation of interleukin-4 by mast cells","volume":"725","author":"Tunon de Lara","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molimm.2016.08.006_bib0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urology.2015.10.017","article-title":"Spontaneous recovery of reflex voiding following spinal cord injury mediated by anti-inflammatory and neuroprotective factors","volume":"88","author":"Tyagi","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.molimm.2016.08.006_bib0240","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1002\/art.22026","article-title":"Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain","volume":"54","author":"Uceyler","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2016.08.006_bib0245","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/01.wnl.0000265062.92340.a5","article-title":"Differential expression of cytokines in painful and painless neuropathies","volume":"69","author":"Uceyler","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.molimm.2016.08.006_bib0250","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/jpet.102.038703","article-title":"Antinociceptive effects of interleukin-4, \u221210, and \u221213 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats","volume":"304","author":"Vale","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.molimm.2016.08.006_bib0255","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbi.2014.10.016","article-title":"Stromal cell-derived CCL2 drives neuropathic pain states through myeloid cell infiltration in injured nerve","volume":"45","author":"Van Steenwinckel","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.molimm.2016.08.006_bib0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2015.04.012","article-title":"In vivo and systems biology studies implicate IL-18 as a central mediator in chronic pain","volume":"283","author":"Vasudeva","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2016.08.006_bib0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0006-8993(94)91566-0","article-title":"Characterization of cytokine-induced hyperalgesia","volume":"654","author":"Watkins","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.molimm.2016.08.006_bib0270","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0006-8993(95)00715-3","article-title":"Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia","volume":"692","author":"Watkins","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.molimm.2016.08.006_bib0275","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0166-2236(00)01854-3","article-title":"Glial activation: a driving force for pathological pain","volume":"24","author":"Watkins","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.molimm.2016.08.006_bib0280","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain: aetiology, symptoms, mechanisms, and management","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2016.08.006_bib0285","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2013.11.055","article-title":"Selective inhibition of STAT1 reduces spinal cord injury in mice","volume":"580","author":"Wu","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molimm.2016.08.006_bib0290","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2013.07.017","article-title":"Activation of mTOR in the spinal cord is required for pain hypersensitivity induced by chronic constriction injury in mice","volume":"111","author":"Zhang","year":"2013","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589016301547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589016301547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T17:22:46Z","timestamp":1749057766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589016301547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":58,"alternative-id":["S0161589016301547"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2016.08.006","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of interleukin-4, the chemokine CCL3 and its receptor CCR5 in neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2016.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}